2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 15:41, 21 November 2023
, 21 November 2023→Clinical Trials
| Line 315: | Line 315: | ||
| | | | ||
|- | |- | ||
| | |{{pmid text|35821806}} | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |{{pmid text|34912838}} | ||
| | | | ||
| | | | ||